Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Other financing activities (2016 - 2026)

Insight Molecular Diagnostics' Other financing activities history spans 4 years, with the latest figure at $487000.0 for Q1 2025.

  • On a quarterly basis, Other financing activities changed N/A to $487000.0 in Q1 2025 year-over-year; TTM through Dec 2025 was $487000.0, a 64.56% decrease, with the full-year FY2025 number at $487000.0, down 64.56% from a year prior.
  • Other financing activities hit $487000.0 in Q1 2025 for Insight Molecular Diagnostics, down from $836000.0 in the prior quarter.
  • Over the last five years, Other financing activities for IMDX hit a ceiling of $2.7 million in Q1 2021 and a floor of -$1000.0 in Q4 2021.
  • Historically, Other financing activities has averaged $907200.0 across 3 years, with a median of $538000.0 in 2024.
  • The widest YoY moves for Other financing activities: up 267500.0% in 2021, down 267500.0% in 2021.
  • Tracing IMDX's Other financing activities over 3 years: stood at -$1000.0 in 2021, then soared by 83700.0% to $836000.0 in 2024, then plummeted by 41.75% to $487000.0 in 2025.
  • Business Quant data shows Other financing activities for IMDX at $487000.0 in Q1 2025, $836000.0 in Q4 2024, and $538000.0 in Q2 2024.